In This Article:
- By insider
President and CEO of Amarin Corp Plc (AMRN) John F Thero sold 607,611 shares of AMRN on 11/12/2018 at an average price of $19.07 a share. The total sale was $11.6 million.
Amarin Corp PLC is a biopharmaceutical company with expertise in lipid science. The company is engaged in commercialization and development of therapeutics to improve cardiovascular health. Amarin Corp PLC has a market cap of $5.08 billion; its shares were traded at around $16.12 with and P/S ratio of 22.44. Amarin Corp PLC had annual average EBITDA growth of 20.90% over the past ten years.
-
Warning! GuruFocus has detected 2 Warning Signs with ATNX. Click here to check it out.
-
The intrinsic value of AMRN
CEO Recent Trades:
-
President and CEO John F Thero sold 607,611 shares of AMRN stock on 11/12/2018 at the average price of $19.07. The price of the stock has decreased by 15.47% since.
Directors and Officers Recent Trades:
-
Chief Scientific Officer Steven B Ketchum sold 17,042 shares of AMRN stock on 10/31/2018 at the average price of $20.74. The price of the stock has decreased by 22.28% since.
-
General Counsel Joseph T Kennedy sold 23,307 shares of AMRN stock on 10/31/2018 at the average price of $20.74. The price of the stock has decreased by 22.28% since.
For the complete insider trading history of AMRN, click here
.This article first appeared on GuruFocus.
-
Warning! GuruFocus has detected 2 Warning Signs with ATNX. Click here to check it out.
-
The intrinsic value of AMRN